Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Liabilities and Shareholders Equity (2022 - 2025)

Neuraxis' Liabilities and Shareholders Equity history spans 4 years, with the latest figure at $5.8 million for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 405.25% year-over-year to $5.8 million; the TTM value through Sep 2025 reached $20.7 million, up 294.73%, while the annual FY2024 figure was $4.8 million, 833.78% up from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $5.8 million at Neuraxis, down from $7.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $7.1 million in Q2 2025 and bottomed at $509498.0 in Q4 2023.
  • The 4-year median for Liabilities and Shareholders Equity is $1.5 million (2023), against an average of $2.7 million.
  • The largest annual shift saw Liabilities and Shareholders Equity plummeted 65.59% in 2023 before it surged 833.78% in 2024.
  • A 4-year view of Liabilities and Shareholders Equity shows it stood at $1.5 million in 2022, then tumbled by 65.59% to $509498.0 in 2023, then soared by 833.78% to $4.8 million in 2024, then grew by 21.41% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Liabilities and Shareholders Equity are $5.8 million (Q3 2025), $7.1 million (Q2 2025), and $3.0 million (Q1 2025).